We have developed a simple and rapid immunocytochemical approach to quantify surface receptor abundance in cultured cells using fluorescence imaging.
Methodenartikel
* These authors contributed equally
We have developed a simple and rapid immunocytochemical approach to quantify surface receptor abundance in cultured cells using fluorescence imaging.
Synaptic transmission is a fundamental process through which neurons communicate. This mechanism involves the release of neurotransmitters—such as GABA, glutamate, and norepinephrine—via exocytosis from presynaptic axon terminals. These neurotransmitters are recognized by specific receptors, including GABAR, AMPAR, and β₂AR, located on the dendritic spine membranes of postsynaptic neurons. The receptors are highly dynamic on the plasma membrane. Conventional immunocytochemical techniques label only the total expression of receptors (Simultaneously labeling all receptors on the membrane surface and within the cells) in cultured cells. Although this provides valuable information for assessing receptor abundance, it does not allow for a precise comparison of whether the number of receptors located on the cell membrane surface has changed. Here, we introduce a method for labeling plasma membrane receptors in neuronal cells using surface immunocytochemistry. By selecting antibodies that specifically recognize the extracellular domain of the receptor, receptors on the cell membrane surface can be labeled outside the intact, impermeable cell membrane.
Synaptic transmission is a fundamental mechanism unique to neuronal cells. In this process, neurotransmitters are released from the presynaptic axon terminal and bind to specific receptors on the postsynaptic membrane, thereby transmitting signals and integrating neurons into highly complex and interconnected neural circuits1,2. Within the presynaptic active zone, synaptic vesicles package neurotransmitters and are transported to the presynaptic membrane with the assistance of specific vesicular transport proteins, which vary depending on the neurotransmitter3,4. These vesicles subsequently release their contents into the synaptic cleft through exocytosis. The released neurotransmitters then bind to receptors on the postsynaptic membrane, transducing the chemical signals into electrical signals to complete information transfer5,6. Because dysregulation of synaptic transmission contributes to the pathogenesis of various neuropsychiatric disorders, investigating its regulatory mechanisms is essential for developing targeted therapeutics7,8,9,10,11.
Conventional immunocytochemical staining assays allow observation of overall expression levels and subcellular localization of target proteins, but cannot capture the dynamics of real-time surface receptors. The fluorescence recovery after photobleaching (FRAP) technique, based on time-lapse imaging of living cells, can be used to evaluate receptor mobility near the cell membrane; however, it requires a relatively complex experimental setup, including an imaging system capable of maintaining cell culture conditions and supporting FRAP. Immunomagnetic bead-based purification of cell membrane components is another method that can quantitatively assess receptor abundance on the cell membrane; however, it cannot evaluate receptor abundance at specific locations within complex cellular structures, such as neuronal dendrites. Here, we used a surface receptor-labeling technique based on immunocytochemistry to quantify receptor transport events in neuronal cells, enabling specification of receptor localization within the cell. This method can also be used to label cell-surface proteins. The straightforward workflow of this approach facilitates monitoring of synaptic transmission and membrane protein trafficking.
1. Preparations for live cell staining
2. Live-cell immunofluorescence staining
3. Image acquisition and analysis
Membrane surface receptor labeling and imaging in primary neurons
The experiments described above were performed in cultured mouse primary neurons, in which surface-localized GABAA receptors were labeled. In parallel, neuronal cell bodies and dendrites were visualized by immunostaining with an anti-MAP2 antibody. Representative images reveal distinct staining patterns for GABAA receptors under different conditions. In non-permeabilized neurons (Figure 1B, top two rows), labeling is predominantly at the cell edge, characterized by a punctate distribution. This indicates that cell membrane integrity was well preserved during the labeling process, with no labeling of GABAA receptors from the intracellular pool. By contrast, upon permeabilization (Figure 1B, bottom two rows), abundant punctate signals are observed throughout the intracellular compartment in addition to the cell surface membrane, suggesting that both intercellular and surface GABAA receptors were labeled. Consequently, the relative level of surface receptors on the cell membrane, as well as the size and fluorescence intensity of individual clusters, can be readily quantified. The specificity of the secondary antibody was confirmed using a control experiment (Supplemental Figure S1).

Figure 1. Representative immunofluorescence images showing surface localization and total pools of GABAA receptors in mouse primary neurons. (A) Maximum intensity projection images from Z-stack scans showing surface staining (left) and total staining (right) of GABAA receptors. MAP2 immunostaining was used to visualize the cell morphology. Intracellularly GABAA receptors are not detected under surface staining conditions. (B) Representative single optical sections (frames) from Z-stacks showing surface staining (top two rows, the GABAA receptor signals in all frames are characterized by a punctate distribution along the edge of the cell membrane contour) and total staining (bottom two rows, the characteristic of the GABAA receptor signal is that it is filled with the cytoplasm of the cell and the dendritic branches in all frames). Please click here to view a larger version of this figure.
Supplemental Figure S1. Validation of secondary antibody specificity. Representative immunofluorescence images showing staining obtained using a primary antibody (anti-IBA1) and fluorescent secondary antibody. DAPI labels nuclei (blue), and IBA1 signal is shown in red. The merged image and higher-magnification region (ROI) demonstrate specific signal localization with minimal background. These data support the specificity of the secondary antibody and the absence of detectable non-specific binding under the staining conditions used. Abbreviation: ROI = region of interest. Please click here to download this file.
The proposed protocol enables accurate quantification of protein expression at the cell membrane. From a functional perspective, the total expression level of membrane receptors does not necessarily correlate with their functional activity5. Functional receptors on the cell membrane surface must be inserted into the membrane so that their extracellular domains can interact with ligands and thus perform their functions. Therefore, the abundance of receptors on the cell membrane surface reflects the relative number of functional receptors, and selective detection of cell surface expression is particularly important. This approach provides a feasible and reliable means of evaluating the relative functional strength of receptors using immunocytochemistry. It is worth noting that this method is particularly suitable for studying processes involving the insertion and removal of cell surface receptors. However, to compare the functional integrity of receptors, it is necessary to experimentally verify the subunit composition of receptors on the cell membrane and the efficiency of signal transduction, rather than relying solely on quantifying the number of receptors at the membrane surface for comparison.
The main advantage of this method is its ability to provide precise analysis at specific subcellular locations, such as primary or secondary dendritic branches of neurons; this advantage is not offered by techniques such as FRAP or membrane component purification. However, this method also has limitations. It does not allow direct visualization of receptor transport, as FRAP does. Furthermore, it requires antibodies that specifically recognize the extracellular domain of the target receptor (e.g., GABA-A receptor α1 monoclonal antibody and GluR1 monoclonal antibody, which are commonly used to detect classical membrane surface receptors in neuronal cells); however, readily available antibodies with such specific binding are not always obtainable for all receptors of research interest.
In studies of synaptic transmission, particularly those investigating the trafficking of postsynaptic receptors such as GABARs, AMPARs, or NMDARs, this method provides a simple and effective approach for quantitatively assessing receptor abundance on the cell surface or specifically within dendrites9,10. This protocol can also be extended to studies investigating changes in membrane receptor expression following pharmacological interventions, such as chemically induced long-term potentiation or long-term depression in cultured neurons.
In protocol step 2.5, the temperature of the fixative is particularly critical. The fixative must be at room temperature when applied to the cells, followed by fixation on ice. Adherence to this step is essential for ensuring the validity of the experimental results. The reliability of the protocol can also be verified during imaging with a laser-scanning confocal microscope by confirming the absence of positive signals inside the cell membrane.
Overall, this immunocytochemical-based membrane protein labeling approach simplifies the study of membrane surface proteins—particularly processes such as receptor endocytosis and membrane insertion—in biomedical research. It also provides a practical platform for the screening and development of membrane protein–targeting drugs, with the potential for rapid and high-throughput screening.
The authors have no conflicts of interest to disclose.
This work was supported by the National Natural Science Foundation of China (82504878 and 82474218), and China Postdoctoral Science Foundation (2025M783897, 2024M752181).
| Name | Unternehmen | Katalognummer | Kommentare |
|---|---|---|---|
| 4% paraformaldehyde | Leagene biotechnology | DF0135 | ICC |
| B-27 Plus neuronal culture system | Thermo Fisher | A3653401 | Cell culture |
| BSA | Solarbio life sciences | A8021 | ICC |
| CaCl2 | Sigma | C7902 | ICC |
| Confocal microscopy | Leica | STELLARIS 8 STED Falcon | ICC |
| Coverslips | Solarbio life sciences | YA0782 | Cell culture |
| Fluoromount-G | SouthernBiotech | 0100-01 | ICC |
| Glucose | Sigma | G6152 | ICC |
| Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 555 | Thermo Fisher | A32727 | ICC |
| Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 | Thermo Fisher | A32731 | ICC |
| Mouse anti-GluR1 | Sigma | MAB2263 | ICC |
| Mouse anti-IBA1 | Synaptic Systems-234 011 | ||
| HEPES | Sigma | H4034 | ICC |
| KCl | Sigma | P9541 | ICC |
| MgCl2 | Sigma | M2670 | ICC |
| Mouse anti-GABA-A receptor | Synaptic Systems | 224 211 | ICC |
| NaCl | Sigma | S3014 | ICC |
| PBS | Gibco | 20012 | ICC |
| Rabbit anti-MAP2 | Cell signal technology | 8707T | ICC |
| Triton X-100 | Sigma | 93443 | ICC |
| Tween-20 | Sigma | P1379 | ICC |
| Solutions, buffers | |||
| Wash buffer I | extracellular buffer or artificial cerebrospinal fluid (ACSF) | ||
| Wash buffer II | phosphate-buffered saline (PBS) containing 0.1% Tween-20 (PBST) | ||
| Blocking buffer I | PBS with 5% bovine serum albumin (BSA) and 5% goat serum | ||
| Blocking buffer II | PBST with 5% BSA and 5% goat serum | ||
| fixative solution | 4% paraformaldehyde | ||
| cell membrane permeabilization agent | 0.3% Triton X-100 in PBS |
Dieser Artikel wurde veröffentlicht
Video demnächst verfügbar